Table 1

Patient characteristics in the presence or absence of any thrombosis (venous or arterial)

AllAbsence of thrombosisPresence of thrombosis
Patients (n)14913316
Age48.3±1.248.4±1.347.5±3.3
Gender (% female)85.984.2100.0
BMI (kg/m2)27.5±0.627.8±0.624.8±0.9
Cholesterol (mg/dL)172±3174±3159±6
Hypertension (%)51.751.156.2
Diabetes (%)6.06.06.2
Ethnicities
 Caucasians (%)55.759.425.0*
 African–Americans (%)34.232.350.0
 Asians (%)4.03.012.5
 Others (%)6.05.312.5
PGA (0–3 cm)0.7±0.10.6±0.20.7±0.2
Clinical SELENA-SLEDAI1.3±0.21.2±0.21.8±0.5
Active disease status ≥4 points (%)18.216.731.2
Treatment information
 Prednisone (%)32.229.356.3*
 Hydroxychloroquine (%)87.286.593.8
 Azathioprine (%)8.17.512.5
 Mycophenolate (%)22.824.012.5
  • Results are expressed as per cent and average (SEM) as appropriate. Significance (p<0.05) is indicated.

  • *P<0.05.

  • BMI, body mass index; PGA, Physician Global Assessment; SELENA-SLEDAI, Safety of Estrogens in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index.